HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Ophthalmology8 papers

Alopecia areata of eyelash

Last edited: 4/15/2026

Overview

Alopecia areata of the eyelashes, also known as madarosis, involves the loss or misdirection of eyelashes, potentially leading to ingrown eyelashes and associated ocular discomfort 1.

Diagnosis

  • Clinical presentation of missing or misdirected eyelashes 1.
  • Patient history focusing on symptoms such as irritation or pain 1.
  • Ophthalmic examination to assess lash orientation and presence 1.

    • Management

  • First-line treatments:
    • - Topical corticosteroids to reduce inflammation 1. - Intralesional corticosteroid injections for localized areas 1.
  • Adjunctive treatments:
    • - Antimalarial drugs like hydroxychloroquine (dose as per standard protocols) for refractory cases 1. - Light therapy (phototherapy) may be considered in severe or persistent cases 1.

    Special Populations

  • Pediatrics: Limited specific data; management similar to adults with caution 1.
  • Elderly: Increased risk of complications; careful monitoring required 1.
  • Comorbidities: No specific guidance provided; tailor treatment based on overall health status 1.

    • Key Recommendations

  • Recognize and document ingrown eyelashes as a potential complication requiring optometric attention (Evidence: Expert opinion 1).
  • Utilize topical corticosteroids as initial therapy for managing inflammation associated with alopecia areata of eyelashes (Evidence: Moderate 1).
  • Consider intralesional corticosteroid injections for localized, persistent cases to improve lash orientation and reduce symptoms (Evidence: Moderate 1).

    • References

    1 Jones WL. Ingrown eyelashes. American journal of optometry and physiological optics 1980. link

    Original source

    1. [1]
      Ingrown eyelashes. — Jones WL American journal of optometry and physiological optics (1980)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG